Definitions and diagnostic criteria

Clinical Diagnosis and Management of Alzheimer’s Disease, Third Edition

Volumn , Issue , 2006, Pages 3-13

  Cummings, Jeffrey L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85121556990     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203931714-4     Document Type: Chapter

References (41)

1. Cummings JL. Cognitive and behavioral heterogeneity in Alzheimer’s disease: seeking the neurological basis. Response to commentaries. Neurobiol Aging 2000; 21: 845-861.
2. The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association at NIoAWG. Consensus report of the Working Group on: molecular and biochemical markers of Alzheimer’s disease. Neurobiol Aging 1998; 19:109-116.
3. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization 1992.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th edn. Washington, DC: American Psychiatric Association 1994.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Revised: DSMIV-TR, 4th edn. Washington, DC: American Psychiatric Association 2000.
6. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984; 34:939-944.
7. Tierney MC, Fisher RH, Lewis AJ, et al. The NINCDSADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer’s disease: a clinicopathologic study of 57 cases. Neurology 1988; 38:359-364.
8. Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 1994; 51:888-895.
9. Erkinjuntti T, Ostbye T, Steenhuis R. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 1997; 337:1667-1674.
10. Kukull WA, Larson EB, Reifler BV, et al. The validity of 3 clinical diagnostic criteria for Alzheimer’s disease. Neurology 1990; 40:1364-1369.
11. Alafuzoff I, Iqbal K, Friden H, et al. Histopathological criteria for progressive dementia disorders: clinical- pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 1987; 74:209-225.
12. Boller F, Lopez OL, Moossy J. Diagnosis of dementia: clinicopathologic correlations. Neurology 1989; 39:76-79.
13. Risse SC, Raskind MA, Nochlin D, et al. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer’s disease. Am J Psychiatry 1990; 147:168-172.
14. Gearing M, Mirra SS, Hedreen JC, et al. The consortium to establish a registry for Alzheimer’s disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 1995; 45:461-466.
15. Petrovitch H, White LR, Ross GW, et al. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology 2001; 57:226-234.
16. McDaniel LD, Lukovits T, McDaniel KD. Alzheimer’s disease: the problem of incorrect clinical diagnosis. J Geriatr Psychiatry Neurol 1993; 6:230-234.
17. Cummings J. Accuracy of the clinical diagnosis of Alzheimer’s disease: review of clinicopathological investigations. Bull Clin Neurosci 1991; 56:5-16.
18. Rasmusson DX, Brandt J, Steele C, et al. Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Disord 1996; 10:180-188.
19. Folstein MF, Folstein SE, McHugh PR. ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
20. Chui HC, Teng EL, Henderson VW, et al. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985; 35:1544-1550.
21. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35:453-461.
22. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65:1863-1872.
23. McKeith IG, Perry RH, Fairburn AF, et al. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 1992; 22:911-922.
24. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of the Lewy body type. Neurology 1994; 44:872-877.
25. Mendez MF, Selwood A, Mastri AR, et al. Pick’s disease versus Alzheimer’s disease: a comparison of clinical characteristics. Neurology 1993; 43:289-292.
26. Abe K, Yorifuji S, Tanabe H, et al. Progressive perceptualmotor impairment without generalized dementia: a type of cortical degenerative syndrome. Behav Neurol 1994; 7:83-86.
27. Caselli RJ, Jack CR, Jr, Petersen RC, et al. Asymmetric cortical degenerative syndromes: clinical and radiologic correlations. Neurology 1992; 42:1462-1468.
28. Confavreux C, Croisile B, Garassus P, et al. Progressive amusia and aprosody. Arch Neurol 1992; 49:971-976.
29. Weintraub S, Rubin N, Mesulam MM. Primary progressive aphasia, longitudinal course, neuropsychological profile, and language features. Ann Neurol 1990; 31:174-183.
30. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: Report of the NINDS-AIREN international workshop. Neurology 1993; 43:250-260.
31. Lopez OL, Larumbe MR, Becker JT, et al. Reliability of NINDS-AIREN clinical criteria for the diagnosis of vascular dementia. Neurology 1994; 44:1240-1245.
32. Gold G, Bouras C, Canuto A, et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. Am J Psychiatry 2002; 159:82-87.
33. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimer’s disease in a community population of older persons: higher than previously reported. JAMA 1989; 262: 2551-2556.
34. Snowden DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997; 277:813-817.
35. Holmes C, Cairns N, Lantos P, et al. Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174:45-50.
36. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1143-1153.
37. Corey-Bloom J, Thal LJ, Galasko D, et al. Diagnosis and evaluation of dementia. Neurology 1995; 45:211-218.
38. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995; 274:1627-1629.
39. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer’s disease. Ann Neurol 1995; 38:6-14.
40. Mayeux R, Saunders AM, Shea S, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. N Engl J Med 1998; 338:506-511.
41. Langlais PJ, Thal L, Hansen L, et al. Neurotransmitters in basal ganglia and cortex of Alzheimer’s disease with and without Lewy bodies. Neurology 1993; 43: 1927-1934.